Extracellular matrix metabolism in diabetic nephropathy

被引:546
|
作者
Mason, RM [1 ]
Wahab, NA [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, Cell & Mol Biol Sect, London SW7 2AZ, England
来源
关键词
D O I
10.1097/01.ASN.0000065640.77499.D7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is characterized by excessive deposition of extracellular matrix proteins in the mesangium and basement membrane of the glomerulus and in the renal tubulointerstitium. This review summarizes the main changes in protein composition of the glomerular mesangium and basement membrane and the evidence that, in the mesangium, these are initiated by changes in glucose metabolism and the formation of advanced glycation end products. Both processes generate reactive oxygen species (ROS). The review includes discussion of how ROS may activate intracellular signaling pathways leading to the activation of redox-sensitive transcription factors. This in turn leads to change in the expression of genes encoding extracellular matrix proteins and the protease systems responsible for their turnover.
引用
收藏
页码:1358 / 1373
页数:16
相关论文
共 50 条
  • [31] Diabetic nephropathy: a disorder of oxygen metabolism?
    Miyata, Toshio
    de Strihou, Charles van Ypersele
    NATURE REVIEWS NEPHROLOGY, 2010, 6 (02) : 83 - 95
  • [32] Tetrahydrobiopterin contributes to the proliferation of mesangial cells and accumulation of extracellular matrix in early-stage diabetic nephropathy
    Wang, Jianyun
    Yang, Qianqian
    Nie, Yaxing
    Guo, Hao
    Zhang, Fan
    Zhou, Xueyan
    Yin, Xiaoxing
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (02) : 182 - 190
  • [33] Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression
    Akahori, H
    Ota, T
    Torita, M
    Ando, H
    Kaneko, S
    Takamura, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (02): : 514 - 521
  • [34] Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy
    Wang, Gang
    Lai, Fernand Mac-Moune
    Chow, Kai-Ming
    Kwan, Bonnie Ching-Ha
    Pang, Wing-Fai
    Luk, Cathy Choi-Wan
    Leung, Chi-Bon
    Li, Philip Kam-Tao
    Szeto, Cheuk-Chun
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (07) : 699 - 706
  • [35] Research progress on small extracellular vesicles in diabetic nephropathy
    Yu, Bingqing
    Wang, Lanfeng
    Mao, Yiping
    Hu, Xinyi
    Lu, Yukang
    He, Jiahui
    Yuan, Xiaoying
    Zhang, Man
    Chen, Zhiping
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2025, 13
  • [36] DIABETIC NEPHROPATHY - MECHANISMS OF MESANGIAL MATRIX EXPANSION
    ABRASS, CK
    WESTERN JOURNAL OF MEDICINE, 1995, 162 (04): : 318 - 321
  • [37] Role of matrix metalloproteinases in development of diabetic nephropathy
    Khasigov, PZ
    Ktzoeva, SA
    Gatagonova, TM
    Tareeva, IE
    Grachev, SV
    Berezov, TT
    BIOCHEMISTRY-MOSCOW, 2000, 65 (05) : 519 - 524
  • [38] Diabetic nephropathy: Where hemodynamics meets metabolism
    Forbes, J. M.
    Fukami, K.
    Cooper, M. E.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (02) : 69 - 84
  • [39] ALDOSE REDUCTASE, GLOMERULAR METABOLISM, AND DIABETIC NEPHROPATHY
    COHEN, MP
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (04): : 55 - 59
  • [40] Regulation of renal extracellular matrix metabolism
    Miyazaki, M
    Nishino, T
    Abe, K
    Furusu, A
    Koji, T
    Kohno, S
    RENAL FIBROSIS, 2003, 139 : 141 - 155